Europe Cryotherapy Market

Europe Cryotherapy Market Size (2023 to 2028)

The cryotherapy market size in Europe is expected to be valued at USD 120.8 million by 2028 from USD 77.54 million in 2023, growing at a CAGR of 9.27% from 2023 to 2028.

The growing cancer patient population in Europe is one of the key factors propelling the European cryotherapy market growth. Approximately 4 million new cases of cancer were reported in Europe in 2020. Cryotherapy has emerged as a promising treatment option for cancers such as prostate, skin, bone, cervical, and liver cancer. For instance, cryotherapy devices can be used to freeze tumor tissue by applying liquid nitrogen directly to the tumor area on the skin, thereby reducing the growth of tumor cells in the body. The growing preference for minimally invasive surgeries further fuels the growth rate of the European cryotherapy market. Cryotherapy treatment involves the use of a cryoprobe device that is inserted into the body through a small incision in the skin. This minimally invasive approach results in shorter recovery times for patients, thereby increasing the demand for cryotherapy devices. This trend is expected to fuel the growth of the cryotherapy market in the forecast period.

The growth of the European cryotherapy market is also driven by the increasing adoption of cryotherapy treatment in beauty spas, fitness centers, and pain management centers in European countries. The usage of cryotherapy treatment is on the rise in the European region, especially in beauty spas to reduce inflammation and puffiness, stimulate collagen production, and tighten pores among other benefits. Cryotherapy treatment is safe for all skin types and has been found to improve skin quality significantly. The rapid adoption of technological developments to manufacture advanced and effective cryotherapy devices and equipment contributes to the growth of the European market. The key market players in Europe have been investing significant amounts in R&D to develop cryotherapy devices for different body parts. Moreover, the establishment of cryotherapy centers by healthcare organizations and key players, coupled with product approvals, is expected to boost the demand for cryotherapy in the European market.

However, factors such as the high costs associated with cryotherapy devices primarily hinder market growth. In addition, poor awareness among people regarding the benefits of cryotherapy, lack of proper infrastructure, strict government regulations, and lack of product approvals in Europe further hamper the regional market growth. Furthermore, the adverse effects of cryotherapy gases and side effects associated with the use of cryotherapy devices such as red skin, mild pain, bleeding, and bone fracture impede the market growth.

This research report on the Europe cryotherapy market has been segmented and sub-segmented into the following categories.

By Product:

• Cryosurgery Devices
  • Tissue Contact Probes
  • Tissue Spray Probes
  • Epidermal and Subcutaneous Cryoablation Devices
• Localized Cryotherapy Devices
• Cryochambers & Cryosaunas

By Application:

• Surgical Applications
  • Oncology
  • Cardiology
  • Dermatology
  • Other Surgical Applications
• Pain Management
• Recovery, Health, and Beauty

By End User:

• Hospitals & Specialty Clinics
• Cryotherapy Centers
• Spas & Fitness Centers

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The European region had the second biggest share of the global market in 2022 and is anticipated to grow at a healthy CAGR during the forecast period owing to the rising adoption of advanced technologies for cancer and pain treatment. The UK led the market in 2022 and is expected to continue dominating the European market throughout the forecast period. The increasing availability of cryotherapy centers in the UK and growing awareness about the benefits of cryotherapy across Europe further drive the UK market growth. Government and healthcare organizations are conducting several awareness programs and utilizing video advertisements on social media and television to promote cryotherapy among the masses. Furthermore, the increasing availability of whole-body cryotherapy treatment is contributing to the growth of the UK cryotherapy market. Cryotherapy centers are investing in advanced infrastructure to provide quality treatment to patients and ensure fast recovery from the disease. The growing number of manufacturing facilities in the UK supports the growth rate of the UK market.

Germany held a substantial share of the European market in 2022 and is anticipated to grow at a noteworthy CAGR during the forecast period. The increasing number of clinical centers for developing various types of cryotherapies boosts the German market growth.

KEY MARKET PLAYERS:

Zimmer MedizinSysteme GmbH, CryoAction Limited, Air Liquide S.A., METRUM CRYOFLEX Sp. z o.o., Cryomed s.r.o., CryoIQ and Cryotherapy Europe are some of the notable companies in the European cryotherapy market.